Current approaches to targeting cancer using antiangiogenesis therapies
- 31 October 1994
- journal article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 20 (4) , 393-412
- https://doi.org/10.1016/0305-7372(94)90020-5
Abstract
No abstract availableThis publication has 74 references indexed in Scilit:
- Potentiation of Metastatic Capacity by Transforming Growth Factor‐β1 Gene TransfectionJapanese Journal of Cancer Research, 1993
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapyThe British Journal of Radiology, 1993
- Tumor Angiogenesis: A New Significant and Independent Prognostic Indicator in Early-Stage Breast CarcinomaJNCI Journal of the National Cancer Institute, 1992
- Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancerThe Lancet, 1992
- Angiogenesis.Journal of Biological Chemistry, 1992
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- Tumor AngiogenesisPublished by Elsevier ,1985
- Endothelial proliferation in tumours and normal tissues: Continuous labelling studiesBritish Journal of Cancer, 1984
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971